Mixing Benadryl, Toradol, and Promethazine in a Single IM Injection
Do not mix diphenhydramine (Benadryl), ketorolac (Toradol), and promethazine together in a single intramuscular injection—there is no compatibility data supporting this three-drug combination, and promethazine carries significant risks of severe tissue injury including gangrene when administered intramuscularly.
Critical Safety Concerns
Promethazine-Specific Risks
Promethazine poses the most significant safety concern in this combination. The FDA drug label explicitly warns that promethazine can cause severe chemical irritation and tissue damage regardless of route of administration 1. Adverse reactions include:
- Burning and pain at injection site
- Tissue necrosis and gangrene
- Severe spasm of distal vessels
- Thrombophlebitis and venous thrombosis
- In severe cases: fasciotomy, skin grafting, or amputation required 1
The drug label also warns of potentially fatal respiratory depression, particularly concerning when combined with other CNS depressants like diphenhydramine 1.
Lack of Compatibility Data
While research demonstrates physical and chemical compatibility between diphenhydramine and ketorolac when mixed together 2, there is no published compatibility data for the three-drug combination you're asking about. The only relevant study examining promethazine combinations focused on psychotropic medications, not this specific mixture 3.
Evidence-Based Alternatives
Separate Injections Approach
Administer these medications as separate intramuscular injections at different sites:
- Ketorolac: 60 mg IM (up to 120 mg/day maximum, not exceeding 5 days) 4
- Diphenhydramine: 25-50 mg IM 5
- Promethazine: 12.5-25 mg IM (if absolutely necessary) 6
This approach eliminates compatibility concerns and reduces the risk of concentrated tissue injury from promethazine.
Two-Drug Compatible Combination
If you must combine medications in a single syringe, diphenhydramine and ketorolac are physically and chemically compatible and can be mixed together 2. Administer promethazine separately if needed.
Clinical Considerations
Additive CNS depression is a major concern. Both diphenhydramine and promethazine cause sedation, and their hypnotic effects are increased when combined 6. This combination requires:
- Close monitoring for respiratory depression
- Availability of reversal agents and airway management equipment
- Reduced dosing of individual agents when used together 6
Cardiovascular effects: All three medications can cause hypotension 6, 7, 6. Promethazine should be infused slowly (25 mg/min when given IV) to minimize this risk 6.
Extrapyramidal reactions: Promethazine carries risk of extrapyramidal effects ranging from restlessness to oculogyric crises 7, 6.
Common Pitfalls to Avoid
- Never assume compatibility without data—mixing incompatible drugs can cause precipitation, inactivation, or increased tissue toxicity
- Don't underestimate promethazine's tissue injury potential—this is a black box-level concern
- Avoid routine use of promethazine IM—consider alternatives like ondansetron for nausea or other antihistamines for sedation
- Don't ignore additive sedation—patients may require prolonged monitoring beyond what you'd expect from single agents
The safest approach is separate injections at different anatomical sites, which eliminates compatibility concerns while maintaining therapeutic efficacy 5, 1.